|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-9-7
|
|
pubmed:abstractText |
Several methods for the identification of patients with prostate carcinoma have been proposed to enhance the clinical usefulness of prostate specific antigen (PSA). However, it remains unclear which method is superior in practical use. The authors attempted prospectively to identify the most powerful method with which to detect prostate carcinoma, especially among patients with intermediate PSA levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2000 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
842-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10951348-Aged,
pubmed-meshheading:10951348-Aged, 80 and over,
pubmed-meshheading:10951348-Humans,
pubmed-meshheading:10951348-Male,
pubmed-meshheading:10951348-Middle Aged,
pubmed-meshheading:10951348-Prognosis,
pubmed-meshheading:10951348-Prospective Studies,
pubmed-meshheading:10951348-Prostate-Specific Antigen,
pubmed-meshheading:10951348-Prostatic Neoplasms,
pubmed-meshheading:10951348-ROC Curve,
pubmed-meshheading:10951348-Regression Analysis,
pubmed-meshheading:10951348-Reproducibility of Results
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma.
|
|
pubmed:affiliation |
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
